all male patients (n = 307) presenting to a sexually transmitted disease (STD) clinic who reported unprotected sex were enrolled in the study. Of these, 63 (20.5%), 19 (6.2%) and one (0.3%) were infected with one, two and three pathogens, respectively. The prevalences of chlamydial infection, gonorrhoea, syphilis, human immunodeficiency virus infection and trichomoniasis were 14.3%, 10.1%, 6.8%, 2.2% and 0%, respectively. The sensitivities of urethral discharge syndrome for detection of chlamydial, gonococcal, and combined forms of infection were 31.8%, 58.5% and 70.0%, respectively, with specificities of 93.5%, 97.1% and 93.9%, respectively. Positive predictive values (PPVs) were 56.0%, 68.0% and 28.0% for chlamydial and gonococcal infections and combinations of the two forms, respectively. In contrast, the sensitivity of genital ulceration syndrome for syphilis detection was only 38.0%, although the specificity was 82.5%, and the PPV was 32.0%. To reduce the number of false-positive results for STD patients who practise unprotected sex, incorporation of risk assessment and rapid diagnostic tests are recommended.
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I N T R O D U C T I O N
Sexually transmitted diseases (STDs), including disease caused by human immunodeficiency virus (HIV), are associated with considerable stigma, morbidity and mortality, and continue to present major medical, social and economic problems worldwide [1] . Neisseria gonorrhoeae was previously the most common STD pathogen; however, its prevalence has declined in developed countries, and it accounts for only 20% of the bacteria isolated from cases of urethritis in recent studies [2] [3] [4] . The profile of STDs has changed during the last 10 years because of a rapid increase in non-gonococcal urethritis (NGU) [5] . Chlamydia trachomatis is now the most common pathogen responsible for urethritis, and accounts for 25-40% of cases [2] . In the USA, c. 19 million individuals (with 25% aged < 20 years) have been infected with one or more STD pathogens [6] . However, despite the global significance of STDs, relatively few epidemiological studies have been undertaken.
Historically, interruption of the transmission of STDs through diagnosis and treatment of infected individuals has formed the cornerstone of public health interventions [7] . Ideally, therapy for STDs should be administered after aetiological diagnosis, at the time of initial clinical presentation. However, in some settings, laboratory tests are often not available because of a lack of laboratory equipment or limited clinical training of laboratory personnel. Consequently, syndromic criteria have been used to provide a rational approach to ensure prompt management of STDs [8] . The syndromic approach, which has been promoted and implemented worldwide, has been a major step towards improving management of these infections in developing countries [9] .
To design locally appropriate syndromic treatment guidelines, it is important to have knowledge of the local STD aetiology and related symptoms. The purpose of the present study was to detail local clinical experience in Taiwan, to investigate the prevalence and epidemiological patterns specific to individual STD-causing pathogens, and to determine the performance of syndromic case management and aetiological diagnosis in the diagnosis and treatment of STDs.
M A T E R I A L S A N D M E T H O D S Setting
The STD clinic of the Taipei City STD Control Center is the national referral centre and offers STD treatment to patients living in the Taipei metropolitan area (population 2 300 000). Some patients are referred by other healthcare providers, but most attend on their own initiative, either for initial treatment of an STD, or because therapy obtained elsewhere has failed.
Study population
From July 2002 to July 2004, new patients (aged > 18 years) who attended the Taipei City STD Control Center clinic were invited to participate in this study. Inclusion criteria were a recent history of unprotected sex and no antibiotic use in the preceding 30 days. Approval for the investigation was obtained from the Institutional Review Board for the protection of human subjects at Taipei City STD Control Center, Taipei, Taiwan. Patients who agreed to participate in the study were asked to complete a questionnaire to determine relevant socio-demographic characteristics, sexual behaviour and current symptoms.
Following genital examination by a physician, blood samples were tested for Treponema pallidum and HIV antibodies. Each participant provided a urine specimen that was tested for N. gonorrhoeae, C. trachomatis and Trichomonas vaginalis.
Laboratory tests
Amplicor PCR tests for C. trachomatis ⁄ N. gonorrhoeae (Roche Diagnostic Systems, Branchburg, NJ, USA) were performed on all individual samples according to the manufacturer's instructions for processing urine specimens [10] . To diagnose Trich. vaginalis, wet-mount microscopy and culture in Whittington media (HiMedia Laboratories, Mumbai, India) were performed on urine specimens. Rapid Plasma Regain (RPR; Spinreact, Girona, Spain) or the Venereal Disease Research Laboratory (VDRL) test [11] was used for syphilis screening, with confirmation by Trep. pallidum haemagglutination assay (TPHA; Gesellschaft fur Biochemica und Diagnostica, Wiesbaden, Germany), following the manufacturer's instructions. Sera positive by both the RPR ⁄ VDRL test (at 1:8 dilution) and the TPHA test were considered to be indicative of active syphilis. For HIV detection, double-ELISA tests (Biosign kits; Princeton BioMeditech, Princeton, NJ, USA) and Western blot assays (Genelabs Diagnostic, Redwood City, CA, USA) were performed. All tests were conducted at the Taipei City STD laboratory. Additional specimens from ten participants were sent to the Taiwan Center for Disease Control (CDC, Taipei, Taiwan) for repetition of some of the laboratory tests (RPR, TPHA and PCR for gonorrhoea and chlamydial infection); agreement between the results obtained by the two laboratories was good (unpublished results).
Epi-Info v. 6.0 (CDC, Atlanta, GA, USA) was used for data analysis. The chi-square ⁄ Fisher's exact test and t-test were used to analyse categorical and continuous variables, respectively, with p £ 0.05 considered to be significant. The relative proportions were calculated for various syndrome and disease prevalences. The sensitivity, specificity, and positive predictive value of the syndromic approach were determined using laboratory test results as the reference.
R E S U L T S Socio-demographic profile and prevalence of laboratory-confirmed STDs
Between July 2002 and July 2004, 307 male patients met the inclusion criteria and were enrolled in the study. The age range was 16-50 years (median 28.5) and most (52.1%) patients were aged < 30 years (Table 1) . Of the 307 patients, 83 (27.0%) were infected with at least one pathogen, with 63 (20.5%), 19 (6.2%) and one (0.3%) being infected with one, two and three pathogens, respectively. The prevalences of (Table 2) .
Prevalence and diagnostic efficacy of STD syndromes
Of the 307 patients, 153 (49.8%) reported genitourinary symptoms, with 93, 40 and 20 cases involving one, two or three symptoms, respectively (Table 1) . Of these symptomatic individuals, 50 were infected with at least one pathogen; however, no pathogens were detected in 103 patients. Compared to the symptomatic cases, there were lower rates of pathogen detection for asymptomatic patients (32.7% vs. 21.4%; p < 0.026). The sensitivity, specificity and positive predictive value of Taiwanese syndromic management guidelines for urethral discharge syndrome (UDS) and genital ulcer syndrome (GUS) are summarised in Table 3 .
D I S C U S S I O N
Of the 307 patients in this study, 83 (27%) were infected with at least one pathogen. The prevalences of C. trachomatis, N. gonorrhoeae, Trep. pallidum, HIV and Trich. vaginalis infection were 14.3%, 10.1%, 6.8%, 2.2% and 0%, respectively, for males attending the STD clinic. No pathogens were detected in a high (73%) proportion of the sample population, perhaps because > 50% (154 ⁄ 307) of patients were asymptomatic. However, 21.4% (33 ⁄ 154) of the asymptomatic individuals in this study who attended the STD clinic were infected with at least one pathogen. Evidence of gonococcal infection was detected in 58% (18 ⁄ 31) of patients seeking treatment for urethral discharge in Taipei. This is consistent with other studies, in which N. gonorrhoeae was found to be the aetiological agent in 53-80% of urethritis cases in developed [12, 13] and developing countries [14] . Concomitant C. trachomatis infection was detected in 32% (10 ⁄ 31) of gonococcal urethritis cases in Taipei. This is comparable with other reports from developed countries, in which 11-34% of patients with gonorrhoea have been shown to be infected also with C. trachomatis, which is the aetiological agent in 15-58% of cases of NGU [13, 15] . Trich. vaginalis is a common pathogen in male patients with urethral discharge [16, 17] , with reported prevalences of 14% and 22% in Malawi [14, 17] ; however, Trich. vaginalis infection was not detected in the present investigation.
HIV infection and syphilis affect similar patient groups and co-infection is common [18] . Most (5 ⁄ 6) HIV-positive patients in the present study also had syphilis, which, like other ulcerative STDs, is associated with enhanced sexual transmission of HIV [19] . Recent outbreaks of syphilis in the UK have raised serious concerns about the sexual health of the population. Syphilis appears more likely to facilitate HIV transmission than any other sexually transmitted infection [20] . Since detection and treatment of syphilis can help to reduce HIV propagation, a penicillin-based regimen should be used for all HIV-positive patients, and careful follow-up is required.
In western Europe, Mycoplasma genitalium has been identified recently as an agent of NGU [21] [22] [23] , and M. genitalium is a more common cause of NGU in Africa than C. trachomatis, being found in 42% of patients with NGU [24] . However, M. genitalium was not detected in the present study.
It has been reported that syndromic management protocols provide adequate treatment for > 90% of patients with GUS [25] , with the reported positive predictive value of the syndromic approach for N. gonorrhoeae infection and ⁄ or chlamydial urethritis being between 75% and 97% in developing countries [26] . The principle strength of the present study was in its relevance for high-risk individuals, since the main patient motivator for testing was recent unprotected sex. Furthermore, the mixture of symptomatic and asymptomatic men provided an opportunity to measure the efficacy of empirical syndromic management of sexually transmitted infections. Overall, the false-negative rate for the UDS-based syndromic management was c. 30-70% for cases of genital infection involving gonococci or chlamydiae, or combined infections, and this approach also resulted in false-positive results for 44%, 32% and 72%, respectively, of UDS cases. Although the specificity was higher for GUS (82.5%), syndromic management based on this syndrome missed 62% of active infections, leading to ulcer treatment in the absence of syphilis in 68% of cases. This lack of diagnostic efficacy imposes a financial burden when treatment is unnecessary, and often deprives asymptomatic individuals of therapeutic intervention when it is required. Thus, even though syndromic management of STDs has been a major step towards improved treatment in developing countries [9] , the present study revealed that its efficacy is limited in cases of UDS and GUS. Incorporation of risk assessment and rapid diagnostic tests can improve the effectiveness of syndromic management. The investigation had several important limitations. Only pathogens that were the target of routine screening in hospitals, plus Chlamydia, N. gonorrhoeae, Trep. pallidum, HIV and Trichomonas, were screened for in the laboratory. This provided key data, but resulted in a missing aetiology for nearly 70% of STD episodes. More intense and costlier examinations for N. gonorrhoeae and a variety of other organisms causing STDs are needed to complete the epidemiological picture. In terms of the therapeutic setting, the urban STD clinic may not adequately reflect patient profiles at other urology and gynaecology hospitals ⁄ clinics. Furthermore, it is possible that patients with severe STDs are less likely to visit these specialist centres. This bias could be corrected in future surveillance studies by including selected local gynaecology and urology clinics and hospitals.
In conclusion, this study demonstrated that the most frequent STD pathogens in Taipei are C. trachomatis, N. gonorrhoeae and Trep. pallidum. UDS and genital ulcers appear to be poor predictors of aetiology in this setting. In order to decrease the number of false-positive STD treatments in patients compromised as a result of unprotected sex, risk assessment and rapid diagnostic tests should be incorporated where necessary.
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